Clex Bio
Business Services · Norway · 1-10 Employees
View Company Info for Free
Overview
Headquarters
Gaustadalléen 21, Oslo, Oslo, 0349, Norw...Website
www.clexbio.comRevenue
<$5 MillionIndustry
ZI Rank: 1
Signal Type
Dec
Jan
Feb
Mar
Apr
May
ZI Rank
1
1
1
1
1
1
About Clex Bio
ClexBio is a Norway-based biotech company creating breakthrough solutions for tissue engineering and single-cell techniques by combining advanced bio-fabrication approaches with its proprietary hydrogel technology CLEX.Explore more
Sell smarter with deeper company insights.
ZoomInfo gives you access to real-time firmographics, buying signals, org charts, and decision-makers - helping your GTM teams prioritize accounts, personalize outreach with AI-driven automation, and close deals faster.
Is Clex Bio your ideal customer? 
Let us give you the heads up on whether it's a good time to reach out
Click to see if Clex Bio had a recent Job posting/layoffs
Check out if Clex Bio is spiking on competitors!
Website visits: Recent activity has been detected on your website
Funding: Get notified immidiatlly once Clex Bio has new funding data
Congratulate Masked Content for being promoted to Masked Content at Clex Bio
Earning: See what the market has to say on Clex Bio recently announced quarterly report
Clex Bio, which may be a good buyer, showed buying intent in Masked Content Topic
Check if Clex Bio has recently received funding, and reach out quickly before it becomes old news!
Competitive Alert! Recent activity has been detected by your competitor Masked Content
Product Launch: Get notified when Clex Bio launches new products
Recommended Actions
Reach out to Masked Content who joined Clex Bio as Masked Content
Find 2 more new buyers
Company Profile Activity
Activity Insights
Clex Bio is experiencing very low activity levels compared to other companies in the Business Services sector.
What does this means?
Clex Bio is drawing exceptional interest within the Business Services industry, suggesting notable developments or strong market momentum, learn more about Clex Bio.
Clex Bio financials insights
Gather financial insights about Clex Bio, including details on funding rounds, investors, total funding, and acquisitions, to gain a comprehensive understanding of their financial strategy.
2021
Angel/Seed
$2.2M
Clex Bio Tech Stack
A closer look at the technologies used by Clex Bio
Most Recent Scoops
Executive Move
Clex Bio has announced that Wasim Malik, Managing Partner, has been appointed to serve on the Board of Directors for the organization.
Board of Directors
Executive Move
Board of Directors
Executive Move
Clex Bio has announced that Wasim Malik, Managing Director for Iaso Ventures, has been appointed to serve on the Board of Directors for the organization.
Board of Directors
Funding
Clex Bio News & Media
ClexBio Appoints Andreas Lehmann and Wasim Malik to Board
OSLO, Norway & BOSTON–(BUSINESS WIRE)–ClexBio, an early-stage biotech company developing next-generation tissue engineered grafts for transplant, is announcing the appointment... Read More The post ClexBio Appoints Andreas Lehmann and Wasim Malik to Board appeared first on citybiz.ClexBio Announces New Appointments to Board of Directors
OSLO, Norway & BOSTON--(BUSINESS WIRE)--ClexBio, an early-stage biotech company developing next-generation tissue engineered grafts for transplant, is announcing the appointment of two new members to its Board of Directors. Joining the board with immediate effect are Andreas Lehmann as non-executive Chairman and Wasim Malik as independent Director. Armend G. Håti, Co-Founder and CEO of ClexBio, will continue to serve on the Board. Mr Lehmann brings an extensive track record from in- and outsideClexBio Oversubscribes Financing Round Totalling USD 2.2M to Develop Engineered Human Blood Vessel Transplants
OSLO, Norway--(BUSINESS WIRE)--ClexBio, a start-up developing bioengineered human blood vessels for transplant, has secured US$2.2m in seed funding from private investors and governmental grants. “The broad backing we have received from international A-level angel investors and top research institutions are strong endorsements of our technology platform and global ambition to transform the engineering of human tissues. We are excited to change the paradigm in this space with the funding we haveSphere Fluidics and ClexBio introduce CYTRIX Microfluidic Hydrogel Kit
CAMBRIDGE, England & OSLO, Norway--(BUSINESS WIRE)--Sphere Fluidics, a company commercializing single cell analysis systems underpinned by its patented picodroplet technology, and ClexBio, a pioneer in solutions for tissue engineering and single-cell techniques, today announced the launch of the biocompatible CYTRIX Microfluidic Hydrogel Kit. The kit combines ClexBio’s novel CYTRIX Hydrogel with Sphere Fluidics’ specially designed Pico-Gen™ double aqueous biochip to allow the plug-and-play gene
Read more news
Top Business Services Companies
Top companies in Australia by revenue
Top companies in New Zealand by revenue
Frequently Asked Questions Regarding Clex Bio
Sign Up For FreeTo access detailed company insights
ClexBio is a Norway-based biotech company creating breakthrough solutions for tissue engineering and single-cell techniques by combining advanced bio-fabrication approaches with its proprietary hydrogel technology CLEX.... Read More
